SuperworthGE HealthCare Technologies price to free cash flow GEHC
Market value divided by free cash flow over the last twelve months, since 2024.
- Today, Oct 23, 2026
- 20.4×
- 3-year median
- 22.5×
- Against its 3-year history
- 18th
- percentile: 0 is its lowest day, 100 its highest
- 3-year range
- 17.8× to 28.4×
- Peer median
- 23.0×
GE HealthCare Technologies' price to free cash flow is 20.4× as of Oct 23, 2026.
That is below its 3-year median of 22.5×, lower than on 82% of days in the last 3 years.
Over that time it ranged from 17.8× in Apr 2025 to 28.4× in Jan 2026.
The median for 9 medical device stocks of a similar size is 23.0×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 20.4× | 18.1× | 28.4× |
| 2025 | 27.2× | 17.8× | 27.8× |
| 2024 | 21.4× | 21.0× | 26.0× |
Against its peers
Companies in Medical - Devices nearest GE HealthCare Technologies' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| GEHCGE HealthCare Technologies | 20.4× |
| DXCMDexCom | 20.9× |
| EWEdwards Lifesciences | 35.8× |
| ZBHZimmer Biomet | 12.3× |
| BSXBoston Scientific | 18.3× |
| SYKStryker | 25.1× |
| MDTMedtronic | 19.9× |
| ABTAbbott Laboratories | n/m |
| LIVNLivaNova | 30.1× |
| ITGRInteger | 38.4× |
| Peer median | 23.0× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on GE HealthCare Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.